MUCOSAL MELANOMA
Clinical trials for MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy before surgery shows promise for advanced melanoma
Disease control OngoingThis study looks at whether giving the immunotherapy drug pembrolizumab both before and after surgery works better than giving it only after surgery for people with stage III or IV high-risk melanoma. About 313 participants will receive pembrolizumab either before and after surge…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 02:00 UTC
-
New drug shows promise in slowing advanced melanoma
Disease control OngoingThis study tests a drug called dinaciclib in 72 people with stage IV melanoma that has spread. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it can shrink tumors or slow the disease, and to check for side effects.
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Can your diet boost cancer treatment? fiber study tests Gut-Immune link
Disease control OngoingThis study is testing whether eating a high-fiber diet can change gut bacteria and improve the immune system's response to immunotherapy in people with advanced melanoma. Fifty patients starting standard immunotherapy will be randomly assigned to eat either a high-fiber diet or a…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 22, 2026 15:59 UTC